Trades on 2 secondary markets

Dewpoint

Dewpoint Therapeutics is a biotechnology company applying the emerging science of biomolecular condensates to drug discovery. Founded in 2018 and headquartered in Boston, Massachusetts, with an additional research site in Dresden, Germany, Dewpoint has built an AI-powered, end-to-end platform (ERSA,

minimal 13.0 / 100 0 APIs View provider profile →

Company Biotechnology Drug Discovery Pharmaceuticals Life Sciences Biomolecular Condensates

Dewpoint is an API provider whose private shares are listed on 2 secondary markets: Forge Global, EquityZen.

Where It Trades

F Forge Global View listing → EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.